HR 5590
115th Congress
House
Health
Congressional oversight
Drug therapy
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Health care costs and insurance
Health care coverage and access
Health information and medical records
Health promotion and preventive care
Health technology, devices, supplies
Medicaid
Medical research
Medicare
Mental health
Public participation and lobbying
Rural conditions and development
Opioid Addiction Action Plan Act
Introduced: April 24, 2018
See on congress.gov
Everywhere this bill has been
15 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 20, 2018
Received in the Senate and Read twice and referred to the Committee on Finance.
Jun 19, 2018
Motion to reconsider laid on the table Agreed to without objection.
Jun 19, 2018
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5247-5248)
Jun 19, 2018
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5247-5248)
Jun 19, 2018
DEBATE - The House proceeded with forty minutes of debate on H.R. 5590.
Jun 19, 2018
Considered under suspension of the rules. (consideration: CR H5247-5249)
Jun 19, 2018
Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
Jun 12, 2018
Placed on the Union Calendar, Calendar No. 580.
Jun 12, 2018
Committee on Ways and Means discharged.
Jun 12, 2018
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-746, Part I.
May 17, 2018
Ordered to be Reported (Amended) by Voice Vote.
May 17, 2018
Committee Consideration and Mark-up Session Held.
May 1, 2018
Referred to the Subcommittee on Health.
Apr 24, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 24, 2018
Introduced in House
Plain-English summary
Opioid Addiction Action Plan Act
(Sec. 2) This bill requires the Centers for Medicare & Medicaid Services (CMS) to develop an action plan to provide recommendations on changes to the Medicare and Medicaid programs to enhance: (1) the treatment and prevention of opioid addiction, and (2) the coverage and payment of medication-assisted treatment for opioid addiction. The CMS must convene a stakeholder meeting to solicit public comment on the action plan.
The CMS must also publish a report that includes an evaluation of price trends for opioid overdose-reversal drugs (e.g., naloxone) and recommendations on ways to lower consumer prices for such drugs.
What's happening now
Received in the Senate and Read twice and referred to the Committee on Finance.
Committees of jurisdiction
4